Bridgewater Associates’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
Bridgewater Associates's PODD Position: Q2 2026 in Review
Bridgewater Associates increased its Insulet (PODD) stake by 343% in Q2 2026, buying an estimated $20.2M and bringing the position to 156,413 shares worth $23.8M. The position accounts for 0.1% of the portfolio, ranked #174.
Bridgewater Associates first reported a position in PODD in Q2 2021 and has held it in 21 quarters since. The position peaked at $27.6M in Q1 2022. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- Bridgewater Associates held 156,413 shares of Insulet worth $23.8M as of Q2 2026.
- Bridgewater Associates bought 121,077 Insulet shares in Q2 2026, an estimated $20.2M.
- Insulet made up 0.1% of Bridgewater Associates's portfolio in Q2 2026, its #174 holding.
- Bridgewater Associates first reported a position in Insulet in Q2 2021 and has held it in 21 quarters since.
- Bridgewater Associates's Insulet position peaked at $27.6M in Q1 2022.
- 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.